Sanxing相关文献与解析，生知库 | 链接生命科学的每一步

Microglial EPOR Contribute to Sevoflurane-induced Developmental Fine Motor Deficits Through Synaptic Pruning in Mice

小胶质细胞EPOR通过突触修剪导致小鼠七氟醚诱导的发育性精细运动障碍

Danyi He ，Xiaotong Shi ，Lirong Liang ，Youyi Zhao ，Sanxing Ma ，Shuhui Cao ，Bing Liu ，Zhenzhen Gao ，Xiao Zhang ，Ze Fan ，Fang Kuang ，Hui Zhang

EPO

Response to immune checkpoint inhibitor combination therapy in metastatic RET-mutated lung cancer from real-world retrospective data

基于真实世界回顾性数据的转移性RET突变肺癌对免疫检查点抑制剂联合疗法的反应

期刊:BMC Cancer

影响因子:3.4

doi:10.1186/s12885-024-11852-3

Yan, Ningning; Zhang, Huixian; Shen, Shujing; Guo, Sanxing; Li, Xingya

Efficacy of chemo-immunotherapy in metastatic BRAF-mutated lung cancer: a single-center retrospective data

化疗联合免疫疗法治疗BRAF突变转移性肺癌的疗效：单中心回顾性数据

期刊:Frontiers in Oncology

影响因子:3.3

doi:10.3389/fonc.2024.1353491

Yan, Ningning; Zhang, Huixian; Guo, Sanxing; Zhang, Ziheng; Xu, Yingchun; Xu, Liang; Li, Xingya

The efficacy of furmonertinib in untreated advanced NSCLC patients with sensitive EGFR mutations in a real-world setting: a single institutional experience

在真实世界环境中，呋莫替尼治疗携带敏感EGFR突变的未经治疗的晚期非小细胞肺癌患者的疗效：一项单中心经验

期刊:Frontiers in Oncology

影响因子:3.3

doi:10.3389/fonc.2024.1331128

Yan, Ningning; Guo, Sanxing; Huang, Siyuan; Zhang, Huixian; Li, Xingya

Case report: The effect of second-line vebreltinib treatment on a patient with advanced NSCLC harboring the MET exon 14 skipping mutation after tepotinib treatment

病例报告：二线维布雷替尼治疗对携带MET 14号外显子跳跃突变的晚期非小细胞肺癌患者在接受替泊替尼治疗后的影响

期刊:Frontiers in Oncology

影响因子:3.3

doi:10.3389/fonc.2024.1331387

Huang, Siyuan; Li, Linlin; Yan, Ningning; Zhang, Huixian; Guo, Qianqian; Guo, Sanxing; Geng, Di; Liu, Xincheng; Li, Xingya

Corrigendum: The efficacy of furmonertinib in untreated advanced NSCLC patients with sensitive EGFR mutations in a real-world setting: a single institutional experience

更正：在真实世界环境中，呋莫替尼治疗携带敏感 EGFR 突变的未经治疗的晚期非小细胞肺癌患者的疗效：一项单中心研究

期刊:Frontiers in Oncology

影响因子:3.3

doi:10.3389/fonc.2024.1412472

Yan, Ningning; Guo, Sanxing; Huang, Siyuan; Zhang, Huixian; Li, Xingya

Camrelizumab combined with anlotinib as second-line therapy for metastatic or recurrent small cell lung cancer: a retrospective cohort study

卡瑞利珠单抗联合安罗替尼作为转移性或复发性小细胞肺癌二线治疗：一项回顾性队列研究

期刊:Frontiers in Oncology

影响因子:3.3

doi:10.3389/fonc.2024.1391828

Shen, Shujing; Li, Xingya; Guo, Sanxing; Xu, Liang; Yan, Ningning

Efficacy of immune checkpoint inhibitors in advanced large cell neuroendocrine carcinoma of the lung: A single‑institution experience

免疫检查点抑制剂治疗晚期肺大细胞神经内分泌癌的疗效：单中心经验

期刊:Oncology Letters

影响因子:2.2

doi:10.3892/ol.2024.14268

Yan, Ningning; Guo, Sanxing; Zhang, Ziheng; Shen, Shujing; Li, Xingya

A Comprehensive Eye-Tracking System Toward Large FOV HMD

面向大视场角头戴式显示器的综合眼动追踪系统

A Survey of Data Augmentation Techniques for Traffic Visual Elements

交通视觉元素数据增强技术综述

Microglial EPOR Contribute to Sevoflurane-induced Developmental Fine Motor Deficits Through Synaptic Pruning in Mice

小胶质细胞EPOR通过突触修剪导致小鼠七氟醚诱导的发育性精细运动障碍

Response to immune checkpoint inhibitor combination therapy in metastatic RET-mutated lung cancer from real-world retrospective data

基于真实世界回顾性数据的转移性RET突变肺癌对免疫检查点抑制剂联合疗法的反应

Efficacy of chemo-immunotherapy in metastatic BRAF-mutated lung cancer: a single-center retrospective data

化疗联合免疫疗法治疗BRAF突变转移性肺癌的疗效：单中心回顾性数据

The efficacy of furmonertinib in untreated advanced NSCLC patients with sensitive EGFR mutations in a real-world setting: a single institutional experience

在真实世界环境中，呋莫替尼治疗携带敏感EGFR突变的未经治疗的晚期非小细胞肺癌患者的疗效：一项单中心经验

Case report: The effect of second-line vebreltinib treatment on a patient with advanced NSCLC harboring the MET exon 14 skipping mutation after tepotinib treatment

病例报告：二线维布雷替尼治疗对携带MET 14号外显子跳跃突变的晚期非小细胞肺癌患者在接受替泊替尼治疗后的影响

Corrigendum: The efficacy of furmonertinib in untreated advanced NSCLC patients with sensitive EGFR mutations in a real-world setting: a single institutional experience

更正：在真实世界环境中，呋莫替尼治疗携带敏感 EGFR 突变的未经治疗的晚期非小细胞肺癌患者的疗效：一项单中心研究

Camrelizumab combined with anlotinib as second-line therapy for metastatic or recurrent small cell lung cancer: a retrospective cohort study

卡瑞利珠单抗联合安罗替尼作为转移性或复发性小细胞肺癌二线治疗：一项回顾性队列研究

Efficacy of immune checkpoint inhibitors in advanced large cell neuroendocrine carcinoma of the lung: A single‑institution experience

免疫检查点抑制剂治疗晚期肺大细胞神经内分泌癌的疗效：单中心经验